Investor Relations
Jan 07, 2019
OPKO Health Appoints Jon R. Cohen, M.D. Executive Chairman of BioReference Laboratories MORE >>
Dec 27, 2018
OPKO Health and OPKO's CEO and Chairman, Dr. Phillip Frost, Announce Proposed Resolution of SEC Action MORE >>
Nov 09, 2018
OPKO Health Reports Third Quarter 2018 Financial Results MORE >>
Nov 08, 2018
BioReference Laboratories Named as Preferred Laboratory with Horizon Healthcare Services MORE >>

SEC Filing Details

Document Details

Filing Date
Apr 30, 2018
Document Date
Apr 30, 2018
Form Description
Additional proxy soliciting materials - definitive
Filing Group
Proxy Filings
Company
OPKO Health, Inc.